
Zivalio-M 10mg/500mg Tablet ER
Marketer
Invision Medi Sciences Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Zivalio-M 10mg/500mg Tablet ER
Diabetic patients with type 2 mellitus may find relief with Zydia-Duo 10mg/500mg Extended-Release tablets, a dual-action medication. This formulation regulates elevated blood glucose, mitigating the risk of severe diabetic complications and offering cardiovascular protection. Zydia-Duo should be ingested with food at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires their consultation to avoid potential hyperglycemia and consequential risks like renal impairment and vision loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is crucial to counteract potential dehydration. Genital fungal infections are a possibility; diligent hygiene is recommended. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption during therapy to minimize adverse effects. Regular blood glucose monitoring is essential while using Zydia-Duo.
Primary Ingredients of Zivalio-M 10mg/500mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Zivalio-M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Zivalio-M 10mg/500mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zivalio-M 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Zivalio-M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Zivalio-M 10mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Zivalio-M 10mg/500mg Extended-Release tablets with a meal.
How Zivalio-M 10mg/500mg Tablet ER works:
The extended-release Zivalio-M tablet (10mg/500mg) combines dapagliflozin and metformin, two medications that manage blood glucose levels. Dapagliflozin increases urinary glucose excretion, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Zivalio-M 10mg/500mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Zivalio-M 10mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Zivalio-M 10mg/500mg tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with kidney impairment, the extended-release Zivalio-M 10mg/500mg tablet requires careful administration. Dosage modification of Zivalio-M 10mg/500mg Tablet ER might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Zivalio-M 10mg/500mg extended-release tablets. Dosage modification of Zivalio-M 10mg/500mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Zivalio-M 10mg/500mg Tablet ER :
Should you forget to take a Zivalio-M 10mg/500mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zivalio-M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
